4
Total investments
3
Early stage
0
Mid stage
0
Late stage
16y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Mar 2022
Transport Authority is engineering the future of oral medications, enabling pharmaceutical-dosed gummies, a currently untapped $300B+ market.
What We Do
• Guaranteed piece-by-piece precision and accuracy down to nanogram levels
• Eliminate consumer and legal risk from active ingredient dose variations
• Enable true prescription-grade gummy medicines for the first time
Why It Matters
• 37% of consumers prefer gummies for taste, ease of swallowing, and faster onset
• Strong benefits for pediatric and geriatric patients who struggle with tablets/capsules
• Gummies dominate supplements, yet the $847B oral pharmaceutical market remains untapped due to manufacturing limitations
What We Unlock
• Conversion of tablets/capsules into gummy or chewable gel dosage forms
• Higher average selling prices and stronger margins compared to pills
• New product line extensions and improved patient adherence
• Access to a $300B+ pharmaceutical gummy opportunity for big pharma
Technology Advantages
• Heat and acid-free dosing unlocks new active ingredient possibilities
• Real-time traceability of active ingredient dosing into each gummy
• GMP-ready, scalable from R&D to high volume manufacturing
• Exceptionally strong, fundamental IP with 72 patents filed in 14 countries
• Exceeds all FDA/EMA requirements
Strategic Impact for Pharmaceutical Brands & CDMOs
• Produce pharmaceutical gummies with verified potency at commercial scale
• Compatible with existing pharmaceutical workflows for seamless adoption
• Transform generic tablets and capsules into proprietary gummies
• Strengthen patient adherence and brand differentiation
Who We Are
• A seasoned Silicon Valley team of scientists and executives
• Developed and scaled worldwide, ultracomplex manufacturing equipment and technology
• $1B IPO and extensive M&A experience
Investor
2021
tvScientific is the first and only CTV advertising platform purpose-built for performance marketers. The tvScientific platform makes TV advertising accessible and measurable for brands and apps of all sizes. tvScientific offers a self-managed solution that simplifies and automates TV buying and optimization, leveraging massive data to prove the actual value of TV advertising. The platform reaches 95% of AVOD inventory using proprietary, deterministic ID technology to measure ad exposure to outcomes in an approachable, radically transparent, and scalable way. An Idealab company, tvScientific was co-founded by senior executives with deep roots in programmatic advertising, digital media, and ad verification. The company is headquartered in El Segundo, California. For more information, visit https://www.tvscientific.com.
Investor and Advisor
2021
Platform Bulb is the only platform for CCPA compliance focused on the unique needs and vendors in the restaurant industry. Integrating with Platform Bulb is seamless and is able to be deployed within just one week.
Investor & Strategic Advisor
2010
Milo is the leading local shopping search with three million products in 50,000 stores across the U.S. Milo shows you whats locally in-stock now. Become a fan @ http://www.facebook.com/MiloShopping.
Milo aggregates the hard-to-find information that millions of consumers are searching for everyday. According to the US Department of Commerce, e-commerce in 2008 accounted for only 3.3% of US retail sales whereas over 87% of US consumers research online and buy offline, according to BIGresearch. Jupiter Research estimates that online product research will impact 40% of total U.S. retail sales by 2011 leading to $1 trillion in sales.
Milos team hails from Google, Apple, and other technology leaders, and was backed and advised by some of Silicon Valleys most prominent entrepreneurs, including from Facebook, Paypal, Blekko, and YouTube before its sale in early December.
Milo.com is now part of the eBay family, and continues to work towards its mission of bringing every product, of every shelf, of every store onto the web!
Experience · 6 entries
All (6)
Investments (4)
Founder (1)
2022
Investor
Mar 2022
Transport Authority is engineering the future of oral medications, enabling pharmaceutical-dosed gummies, a currently untapped $300B+ market.
What We Do
• Guaranteed piece-by-piece precision and accuracy down to nanogram levels
• Eliminate consumer and legal risk from active ingredient dose variations
• Enable true prescription-grade gummy medicines for the first time
Why It Matters
• 37% of consumers prefer gummies for taste, ease of swallowing, and faster onset
• Strong benefits for pediatric and geriatric patients who struggle with tablets/capsules
• Gummies dominate supplements, yet the $847B oral pharmaceutical market remains untapped due to manufacturing limitations
What We Unlock
• Conversion of tablets/capsules into gummy or chewable gel dosage forms
• Higher average selling prices and stronger margins compared to pills
• New product line extensions and improved patient adherence
• Access to a $300B+ pharmaceutical gummy opportunity for big pharma
Technology Advantages
• Heat and acid-free dosing unlocks new active ingredient possibilities
• Real-time traceability of active ingredient dosing into each gummy
• GMP-ready, scalable from R&D to high volume manufacturing
• Exceptionally strong, fundamental IP with 72 patents filed in 14 countries
• Exceeds all FDA/EMA requirements
Strategic Impact for Pharmaceutical Brands & CDMOs
• Produce pharmaceutical gummies with verified potency at commercial scale
• Compatible with existing pharmaceutical workflows for seamless adoption
• Transform generic tablets and capsules into proprietary gummies
• Strengthen patient adherence and brand differentiation
Who We Are
• A seasoned Silicon Valley team of scientists and executives
• Developed and scaled worldwide, ultracomplex manufacturing equipment and technology
• $1B IPO and extensive M&A experience
2021
Investor
2021
tvScientific is the first and only CTV advertising platform purpose-built for performance marketers. The tvScientific platform makes TV advertising accessible and measurable for brands and apps of all sizes. tvScientific offers a self-managed solution that simplifies and automates TV buying and optimization, leveraging massive data to prove the actual value of TV advertising. The platform reaches 95% of AVOD inventory using proprietary, deterministic ID technology to measure ad exposure to outcomes in an approachable, radically transparent, and scalable way. An Idealab company, tvScientific was co-founded by senior executives with deep roots in programmatic advertising, digital media, and ad verification. The company is headquartered in El Segundo, California. For more information, visit https://www.tvscientific.com.
Investor and Advisor
2021
Platform Bulb is the only platform for CCPA compliance focused on the unique needs and vendors in the restaurant industry. Integrating with Platform Bulb is seamless and is able to be deployed within just one week.
2015
Principal
2015
Atomic is the venture studio that pioneered the model of starting companies by pairing founders with the best ideas, teams, and resources. When entrepreneurs team up with Atomic, they join a group of experienced founders and a ready-made team of experts who have successfully built many companies, generating billions of dollars in value. Our fourth fund of $320 million is used exclusively to fund companies started at Atomic.
2011
CEO & Co-Founder
2011
LoveIt is a place where you can search, discover and visually bookmark the web. Import, organize and curate your findings. Collaborate and share in public or private collections. Stay tuned as we roll out improvements and new features!
http://loveit.com/
https://twitter.com/LoveIt
https://www.facebook.com/LoveIt
Show all 6 entries ↓
Investment activity
2010–2022 · 4 investments
Recent (last 2 years)Earlier
